Table 1.
Baseline patient characteristics
|
Characteristic |
ER positive |
ER negative |
Total |
|||
|---|---|---|---|---|---|---|
| No. of patients | % | No. of patients | % | No. of patients | % | |
|
No. of patients |
40 |
76.9 |
12 |
23.1 |
52 |
100 |
|
Age, years |
|
|
|
|
|
|
| Range |
42.9–82.8 |
59.4–82.5 |
42.9–82.8 |
|||
| Median |
70.0 |
67.7 |
69.5 |
|||
|
FIGO stage* |
|
|
|
|
52 |
100 |
| I |
13 |
32.5 |
9 |
75.0 |
22 |
42.3 |
| II |
6 |
15.0 |
1 |
8.3 |
7 |
13–5 |
| III |
11 |
27.5 |
2 |
16.7 |
13 |
25.0 |
| IV |
10 |
25.0 |
0 |
0 |
10 |
19.2 |
|
Grade |
|
|
|
|
52 |
100 |
| Well differentiated |
7 |
17.5 |
0 |
0 |
7 |
13.5 |
| Mod. differentiated |
17 |
42.5 |
7 |
58.3 |
24 |
46.2 |
| Poorly differentiated |
14 |
35.0 |
5 |
41.7 |
19 |
36.5 |
| Not specified |
2 |
5.0 |
0 |
0 |
2 |
3.8 |
|
Disease status at inclusion |
|
|
|
|
52 |
100 |
| Relapse |
26 |
65 |
8 |
66.7 |
34 |
65.4 |
| Primary metastatic disease |
14 |
35 |
4 |
33.3 |
18 |
34.6 |
|
Previous treatment |
|
|
|
|
52 |
100 |
| Surgery alone |
11 |
27.5 |
1 |
8.3 |
12 |
23.1 |
| Surgery and radiation |
8 |
20.0 |
1 |
8.3 |
9 |
17.3 |
| Surgery and chemotherapy |
7 |
17.5 |
3 |
25.0 |
10 |
19.2 |
| Surgery, radiation and chemotherapy | 14 | 35.0 | 7 | 58.3 | 21 | 40.4 |
*Stage at primary diagnosis.